美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=PALIPERIDONE PALMITATE"
符合检索条件的记录共 17 条
共 1 页，当前第 1 页
返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
PALIPERIDONE PALMITATE 211149 001 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 39MG/0.25ML (39MG/0.25ML) No No 2021/07/06 2021/07/06 TEVA PHARMS USA Prescription
PALIPERIDONE PALMITATE 211149 002 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 78MG/0.5ML (78MG/0.5ML) No No 2021/07/06 2021/07/06 TEVA PHARMS USA Prescription
PALIPERIDONE PALMITATE 211149 003 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 117MG/0.75ML (117MG/0.75ML) No No 2021/07/06 2021/07/06 TEVA PHARMS USA Prescription
PALIPERIDONE PALMITATE 211149 004 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 156MG/ML (156MG/ML) No No 2021/07/06 2021/07/06 TEVA PHARMS USA Prescription
PALIPERIDONE PALMITATE 211149 005 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 234MG/1.5ML (156MG/ML) No No 2021/07/06 2021/07/06 TEVA PHARMS USA Prescription
PALIPERIDONE PALMITATE 211995 001 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 39MG/0.25ML No No 2023/06/30 (TA) -- TOLMAR None (Tentative Approval)
PALIPERIDONE PALMITATE 211995 002 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 78MG/0.5ML No No 2023/06/30 (TA) -- TOLMAR None (Tentative Approval)
PALIPERIDONE PALMITATE 211995 003 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 117MG/0.75ML No No 2023/06/30 (TA) -- TOLMAR None (Tentative Approval)
PALIPERIDONE PALMITATE 211995 004 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 156MG/ML No No 2023/06/30 (TA) -- TOLMAR None (Tentative Approval)
PALIPERIDONE PALMITATE 211995 005 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 234MG/1.5ML No No 2023/06/30 (TA) -- TOLMAR None (Tentative Approval)
PALIPERIDONE PALMITATE 210397 001 ANDA PALIPERIDONE PALMITATE SUSPENSION;EXTENDED RELEASE No No 2024/02/05 (TA) -- PHARMASCIENCE INC None (Tentative Approval)
PALIPERIDONE PALMITATE 216228 001 ANDA PALIPERIDONE PALMITATE SUSPENSION, EXTENDED RELEASE;INJECTABLE 273MG/0.88ML No No 2024/05/20 (TA) -- MYLAN PHARMS INC None (Tentative Approval)
PALIPERIDONE PALMITATE 215682 002 ANDA PALIPERIDONE PALMITATE INJECTION;SUSPENSION 410MG/1.315ML No No 2024/12/03 (TA) -- MYLAN PHARMACEUTICALS INC A VIATRIS CO None (Tentative Approval)
PALIPERIDONE PALMITATE 215682 003 ANDA PALIPERIDONE PALMITATE INJECTION;SUSPENSION 546MG/1.75ML No No 2024/12/03 (TA) -- MYLAN PHARMACEUTICALS INC A VIATRIS CO None (Tentative Approval)
PALIPERIDONE PALMITATE 215682 004 ANDA PALIPERIDONE PALMITATE INJECTION;SUSPENSION 819MG/2.625ML No No 2024/12/03 (TA) -- MYLAN PHARMACEUTICALS INC A VIATRIS CO None (Tentative Approval)
PALIPERIDONE PALMITATE 215682 005 ANDA PALIPERIDONE PALMITATE INJECTION;SUSPENSION 1092MG/3.5ML No No 2024/12/03 (TA) -- MYLAN PHARMACEUTICALS INC A VIATRIS CO None (Tentative Approval)
PALIPERIDONE PALMITATE 215682 006 ANDA PALIPERIDONE PALMITATE INJECTION;SUSPENSION 1560MG/5.0ML No No 2024/12/03 (TA) -- MYLAN PHARMACEUTICALS INC A VIATRIS CO None (Tentative Approval)
药品名称，活性成分，申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database